Intuitive Surgical Inc, a mega-cap stock valued at $205.8 billion, is a leader in robotic-assisted surgery with its da Vinci system. Despite a recent 6.8% dip from its 52-week high, ISRG stock has gained 21.1% over the last three months, outperforming the Nasdaq Composite. In the long term, ISRG shares have risen 10% YTD and 5.9% over the past year, trading above its 50-day and 200-day moving averages since late October. In Q3, ISRG reported revenue of $2.51 billion, beating analyst expectations by 3.9%, with adjusted EPS of $2.40 surpassing estimates of $1.99. Wall Street analysts have a consensus “Moderate Buy” rating on ISRG, with a mean price target of $610.28 suggesting a potential upside of 6.3% from current levels. Cooper Companies, Inc. lags behind ISRG in the medical instruments & supplies industry, with a 15.2% YTD loss and a 24.1% decline over the past 52 weeks.

Read more at Barchart: Is Intuitive Surgical Stock Underperforming the Nasdaq?